The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes of a late second autologous hematopoietic stem cell transplant compared to nontransplantation salvage therapy in relapsed multiple myeloma after upfront transplant.
J. M. Azar
No relevant relationships to disclose
S. Abdelqader
No relevant relationships to disclose
R. Abonour
No relevant relationships to disclose
A. Suvannasankha
No relevant relationships to disclose
R. Tabbey
No relevant relationships to disclose
S. Farag
No relevant relationships to disclose